Including another neurotech device that’s focused on treating obesity risk and promoting weight loss by targeting biological mechanisms that store visceral fat.
She’s also upbeat about where the neurotech market is headed – pointing to projections that brain-targeting medtech is poised for major growth over the next five years.
It’s a very different investment.”A cost efficient, scalable market opportunityWhat about market opportunity?
Given how many conditions and diseases medtech neurotech builders are eyeing this could end up scaling considerably, too, in the coming years.
These first, lower risk neurotech products offer a chance for Neurovalens to test how much appetite there is for wearable neurotech in healthcare...
News articles remains the property of the source. Tellbrief is a news aggregator.
